News & Media Archives - BAKX Therapeutics

February 1, 2023
Silicon Review

BAKX Therapeutics — unlocking the full therapeutic power of the biological pathways that control cell life and death
read more
January 3, 2023
Life Science Leader

Why Founder CEOs Deliver In Bear Markets
read more
November 16, 2022
BusinessWire

BAKX Welcomes Dr. Marina Konopleva to Its Scientific Advisory Board
read more
March 15, 2022
BioWorld

Activating activators is strategy against apoptosis defectors
read more
January 5, 2022
BAKX Press Release

BAKX Expands Scientific Advisory Board
read more
November 21, 2021
Nicole DeFedis, Endpoints News

Months after massive Ipsen deal, BAKX Therapeutics nets more cash for its ‘Thelma and Louise’ approach to cancer cell death
read more
November 18, 2021
News Daily

BAKX Therapeutics Raises $25M Series A Round
read more
November 18, 2021
BusinessWire

BAKX Raises $25 Million to Develop Therapeutics Targeting Pro-Apoptotic Proteins and Mitochondrial Apoptosis Pathway
read more
July 27, 2021
Yahoo!

Ipsen Beefs Up Pre-Clinical Oncology Pipeline With Over $850M Deal With BAKX Therapeutics
read more
July 27, 2021
BusinessWire

BAKX Therapeutics enters world-wide collaboration agreement with Ipsen for BKX-001
read more